Skip to content
ClinCalc Pro
Menu
Antifungal (Azole) — Topical/Vaginal

Clotrimazole (Vulvovaginal Candidiasis)

Brand names: Canesten, Canesten Combi

This is intravaginal clotrimazole, an imidazole antifungal supplied as pessaries, vaginal tablets or internal cream for the treatment of vulvovaginal candidiasis (thrush).

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It inhibits fungal ergosterol synthesis, disrupting the cell membrane of Candida species and producing a fungistatic to fungicidal effect locally within the vagina.

Prescribing in practice

  • The pessary or vaginal cream base can damage latex condoms and diaphragms, so warn that barrier contraception may fail during use.
  • Intravaginal clotrimazole is suitable in pregnancy for confirmed thrush, though an applicator should be used with care; oral azoles are avoided in pregnancy.
  • Investigate or seek review for recurrent, atypical or treatment-failing symptoms rather than repeated empirical courses.

Monitoring

No laboratory monitoring is required; review symptom resolution and consider a swab if treatment fails or symptoms recur.

Counselling the patient

  • Insert the pessary high into the vagina, ideally at night.
  • Do not rely on latex condoms or diaphragms during and for a few days after treatment.
  • Some accompanying vulval cream may be needed for external itching.

Evidence & guidelines

Intravaginal clotrimazole is a well-established, effective treatment for uncomplicated vulvovaginal candidiasis and is the preferred topical option in pregnancy.

Reference: BASHH VVC Guideline 2019; NICE CKS Thrush (Vaginal); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.